-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Edwards Lifesciences, Raises Price Target to $88

Benzinga·12/05/2025 12:48:19
语音播报
Baird analyst David Rescott maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $83 to $88.